Biotech ETF tops key $300 level for first time since January

Biotech stocks were trading higher Thursday afternoon and reached the highest they have been since January 2016.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.